Announcements Trials
Browse Landscape

Status

No longer available 1Available 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 72Observational 5Expanded_access 2

Sponsor

Cancer Type

Myeloid 2

Conditions

Polycythemia Vera 2Primary Myelofibrosis 1

Interventions

nilotinib 4ruxolitinib 2ponatinib 2venetoclax 1selinexor 1navitoclax 1midostaurin 1fludarabine phosphate 1asciminib 1Whole-Body Irradiation 1Transplantation 1Tacrolimus 1Mycophenolic Acid 1Imatinib Mesylate 1Dasatinib 1Cytarabine 1Cord Blood Stem Cell Transplantation 1Busulfan 1Bone Marrow Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Expanded_access × ruxolitinib × Myeloid × Clear all
NCT04745637 2025-11-18

Managed Access Programs for INC424, Ruxolitinib

Novartis

Available
Myeloid

Polycythemia Vera, Primary Myelofibrosis

NCT05269771 2025-11-05

MAP to Provide Access to Ruxolitinib, for Patients With Polycythemia Vera

Novartis

No longer available
Myeloid

Polycythemia Vera

Data powered by HemOnc (CC BY 4.0) Colophon âš¡